Clinical Trial Update: Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses the combination of entecavir and adefovir in lamivudine-resistant chronic hepatitis B patients who fail lamivudine plus adefovir; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2014-01-13